These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 25963649)

  • 1. LC-MS/MS-based quantification of cholesterol and related metabolites in dried blood for the screening of inborn errors of sterol metabolism.
    Becker S; Röhnike S; Empting S; Haas D; Mohnike K; Beblo S; Mütze U; Husain RA; Thiery J; Ceglarek U
    Anal Bioanal Chem; 2015 Jul; 407(17):5227-33. PubMed ID: 25963649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A routine method for cholesterol and 7-dehydrocholesterol analysis in dried blood spot by GC-FID to diagnose the Smith-Lemli-Opitz syndrome.
    Gelzo M; Clericuzio S; Barone R; D'Apolito O; Dello Russo A; Corso G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 907():154-8. PubMed ID: 22985726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct analysis of sterols from dried plasma/blood spots by an atmospheric pressure thermal desorption chemical ionization mass spectrometry (APTDCI-MS) method for a rapid screening of Smith-Lemli-Opitz syndrome.
    Paglia G; D'Apolito O; Gelzo M; Dello Russo A; Corso G
    Analyst; 2010 Apr; 135(4):789-96. PubMed ID: 20349543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sample storage on 7- and 8-dehydrocholesterol levels analysed on whole blood spots by gas chromatography-mass spectrometry-selected ion monitoring.
    Corso G; Rossi M; De BD; Rossi I; Parenti G; Dello RA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jan; 766(2):365-70. PubMed ID: 11824824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients.
    Griffiths WJ; Abdel-Khalik J; Crick PJ; Ogundare M; Shackleton CH; Tuschl K; Kwok MK; Bigger BW; Morris AA; Honda A; Xu L; Porter NA; Björkhem I; Clayton PT; Wang Y
    J Steroid Biochem Mol Biol; 2017 May; 169():77-87. PubMed ID: 26976653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smith-Lemli-Opitz syndrome with a classical phenotype, oesophageal achalasia and borderline plasma sterol concentrations.
    Haas D; Armbrust S; Haas JP; Zschocke J; Mühlmann K; Fusch C; Neumann LM
    J Inherit Metab Dis; 2005; 28(6):1191-6. PubMed ID: 16435228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of Smith-Lemli-Opitz syndrome by ultraviolet spectrophotometry.
    Scalco FB; Cruzes VM; Vendramini RC; Brunetti IL; Moretti-Ferreira D
    Braz J Med Biol Res; 2003 Oct; 36(10):1327-32. PubMed ID: 14502364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of 7-dehydrocholesterol in plasma and amniotic fluid by liquid chromatography/particle beam-mass spectrometry as a biochemical diagnostic marker for the Smith-Lemli-Opitz syndrome.
    Sattler W; Leis HJ; Kostner GM; Malle E
    Rapid Commun Mass Spectrom; 1995; 9(13):1288-92. PubMed ID: 8527820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assays of plasma dehydrocholesteryl esters and oxysterols from Smith-Lemli-Opitz syndrome patients.
    Liu W; Xu L; Lamberson CR; Merkens LS; Steiner RD; Elias ER; Haas D; Porter NA
    J Lipid Res; 2013 Jan; 54(1):244-53. PubMed ID: 23072947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pitfalls in measuring plasma cholesterol in the Smith-Lemli-Opitz syndrome.
    Jira PE; de Jong JG; Janssen-Zijlstra FS; Wendel U; Wevers RA
    Clin Chem; 1997 Jan; 43(1):129-33. PubMed ID: 8990234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and Clinical Effects of Vitamin E Supplementation in Hungarian Smith-Lemli-Opitz Syndrome Patients.
    Koczok K; Horváth L; Korade Z; Mezei ZA; Szabó GP; Porter NA; Kovács E; Mirnics K; Balogh I
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biochemical screening for Smith-Lemli-Opitz syndrome. Italian SLOS Collaborative Group.
    Guzzetta V; De Fabiani E; Galli G; Colombo C; Corso G; Lecora M; Parenti G; Strisciuglio P; Andria G
    Acta Paediatr; 1996 Aug; 85(8):937-42. PubMed ID: 8863875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol supplementation with egg yolk increases plasma cholesterol and decreases plasma 7-dehydrocholesterol in Smith-Lemli-Opitz syndrome.
    Linck LM; Lin DS; Flavell D; Connor WE; Steiner RD
    Am J Med Genet; 2000 Aug; 93(5):360-5. PubMed ID: 10951458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts.
    Kelley RI
    Clin Chim Acta; 1995 Apr; 236(1):45-58. PubMed ID: 7664465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid UPLC-MS/MS method for simultaneous separation of 48 acylcarnitines in dried blood spots and plasma useful as a second-tier test for expanded newborn screening.
    Gucciardi A; Pirillo P; Di Gangi IM; Naturale M; Giordano G
    Anal Bioanal Chem; 2012 Aug; 404(3):741-51. PubMed ID: 22766757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D levels in Smith-Lemli-Opitz syndrome.
    Movassaghi M; Bianconi S; Feinn R; Wassif CA; Porter FD
    Am J Med Genet A; 2017 Oct; 173(10):2577-2583. PubMed ID: 28796426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smith-Lemli-Opitz Syndrome in a newborn infant with developmental abnormalities and low endogenous cholesterol.
    Yang Y; Yassan L; Leung EKY; Yeo KJ
    Clin Chim Acta; 2018 Apr; 479():208-211. PubMed ID: 29355488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of sterol analysis by liquid chromatography-tandem mass spectrometry for the prenatal diagnosis of Smith-Lemli-Opitz syndrome.
    Griffiths WJ; Wang Y; Karu K; Samuel E; McDonnell S; Hornshaw M; Shackleton C
    Clin Chem; 2008 Aug; 54(8):1317-24. PubMed ID: 18556335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between biomarkers and clinical severity in patients with Smith-Lemli-Opitz syndrome.
    Oláh AV; Szabó GP; Varga J; Balogh L; Csábi G; Csákváry V; Erwa W; Balogh I
    Eur J Pediatr; 2013 May; 172(5):623-30. PubMed ID: 23319240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An oxysterol biomarker for 7-dehydrocholesterol oxidation in cell/mouse models for Smith-Lemli-Opitz syndrome.
    Xu L; Korade Z; Rosado JDA; Liu W; Lamberson CR; Porter NA
    J Lipid Res; 2011 Jun; 52(6):1222-1233. PubMed ID: 21402677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.